Prevalence of clinically meaningful antiphospholipid antibodies in patients with systemic lupus erythematosus varies by race and ethnicity

Saved in:
Bibliographic Details
Published inAnnals of the rheumatic diseases Vol. 83; no. 3; pp. 404 - 406
Main Authors Yelnik, Cécile M, Xie, Xianhong, Guerra, Marta M, Costedoat-Chalumeau, Nathalie, Khosroshahi, Arezou, Kamen, Diane L, Schwartz, Noa, Katz, Patricia, Minett, Margaret, Amoss, R Toby, Fu, April, Guettrot-Imbert, Gaëlle, Lazaro, Estibaliz, Le Guern, Véronique, Oates, Jim, Dall'Era, Maria, Yazdany, Jinoos, Molto, Anna, Kim, Mimi Y, Salmon, Jane E
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Ltd and European League Against Rheumatism 01.03.2024
BMJ Publishing Group LTD
BMJ Publishing Group
Subjects
Antibodies
Antibodies, Antiphospholipid
Anticoagulants
Antiphospholipid antibodies
Antiphospholipid Syndrome
Epidemiology
Ethnicity
Humans
Laboratories
Letter
Life Sciences
Lupus
Lupus Erythematosus, Systemic
Observational studies
Patients
Prevalence
Race
Rheumatology
Systemic lupus erythematosus
New York
United States > US
Epidemiology
Lupus Erythematosus, Systemic
Antibodies, Antiphospholipid
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
PMCID: PMC10922457
ISSN:0003-4967
1468-2060
DOI:10.1136/ard-2023-224952